| 000 | 01565 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250516141727.0 | ||
| 264 | 0 | _c20140625 | |
| 008 | 201406s 0 0 eng d | ||
| 022 | _a1827-1596 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRoquilly, A | |
| 245 | 0 | 0 |
_aAmmonia plasma concentration and prolonged infusion of remifentanil in patients with acute kidney injury. _h[electronic resource] |
| 260 |
_bMinerva anestesiologica _cAug 2013 |
||
| 300 |
_a884-90 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study | ||
| 650 | 0 | 4 |
_aAcute Kidney Injury _xblood |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAmmonia _xblood |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aCritical Care |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGlycine _xblood |
| 650 | 0 | 4 | _aHemodiafiltration |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypnotics and Sedatives _xadverse effects |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPiperidines _xadverse effects |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRemifentanil |
| 700 | 1 | _aPerbet, S | |
| 700 | 1 | _aSimonneau, F | |
| 700 | 1 | _aCinotti, R | |
| 700 | 1 | _aSebille, V | |
| 700 | 1 | _aVolteau, C | |
| 700 | 1 | _aGratas, C | |
| 700 | 1 | _aMinet-Quinard, R | |
| 700 | 1 | _aLoutrel, O | |
| 700 | 1 | _aRozec, B | |
| 700 | 1 | _aLejus, C | |
| 700 | 1 | _aConstantin, J M | |
| 700 | 1 | _aAsehnoune, K | |
| 773 | 0 |
_tMinerva anestesiologica _gvol. 79 _gno. 8 _gp. 884-90 |
|
| 999 |
_c22597961 _d22597961 |
||